BioSyent Schedules First Quarter 2026 Earnings Release for May 14, 2026

Stock Information for Biosyent Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Biosyent Inc

BioSyent Announces Health Canada Approval of Thyconvi(TM) (levothyroxine oral solution)
BioSyent Declares Second Quarter 2026 Dividend
BioSyent Releases Financial Results for First Quarter 2026
BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference
FeraMAX is Canada's Top-Ranked Iron Supplement for 11 Consecutive Years
BioSyent Announces Grant of Restricted Share Units
BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025
BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.